Skip to main content
logo
Hinova Pharmaceuticals Inc. (SHA:688302)
China flag China · Delayed Price · Currency is CNY
33.65
+0.05 (0.15%)
At close: Sep 23, 2026

Hinova Pharmaceuticals Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,3324,8693,0415,1563,992-
Market Cap Growth
-37.51%60.11%-41.02%29.14%--
Enterprise Value
2,6524,0582,1413,9912,299-
Last Close Price
33.6549.1730.7152.0740.32-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
53.50237.848289.18-2418.38-
PB Ratio
3.314.582.553.772.52-
P/TBV Ratio
3.414.722.623.862.57-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
42.59198.255837.54-1392.58-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.100.100.010.010.020.01
Net Debt / Equity Ratio
-0.67-0.71-0.70-0.80-0.97-1.14
Net Debt / EBITDA Ratio
4.154.443.703.264.432.62
Net Debt / FCF Ratio
4.153.923.023.083.993.62
Asset Turnover
0.050.020-0.00-
Inventory Turnover
0.210.2066.31-134.51-
Quick Ratio
5.766.825.7510.3411.354.71
Current Ratio
6.177.206.0310.7411.654.99
Return on Equity (ROE)
-12.27%-12.17%-15.59%-19.93%-25.40%-34.50%
Return on Assets (ROA)
-8.00%-8.12%-9.98%-13.04%-16.00%-19.89%
Return on Capital Employed (ROCE)
-15.00%-14.70%-18.80%-24.30%-21.80%-43.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.95%-2.82%-6.56%-5.71%-7.55%-
FCF Yield
-4.92%-3.94%-9.10%-6.88%-9.62%-
Buyback Yield / Dilution
1.26%0.51%-0.21%-9.06%-22.21%-5.74%